Back
10x Genomics 10K Form
Buy
59
TXG
10x Genomics
Last Price:
42.20
Seasonality Move:
7.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TXG News And Ratings
See the #1 stock for the next 7 days that we like better than TXG
TXG Financial Statistics
Sales & Book Value
| Annual Sales: | $516.41M |
|---|---|
| Cash Flow: | $-40.74M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.30 |
| Price / Book: | 6.69 |
Profitability
| EPS (TTM): | -1.91000 |
|---|---|
| Net Income (TTM): | $-223.36M |
| Gross Margin: | $396.02M |
| Return on Equity: | -28.47% |
| Return on Assets: | -22.44% |
10x Genomics Earnings Forecast
Key 10x Genomics Financial Ratios
- The Gross Profit Margin over the past 6 years for TXG is 76.69%.
- The Selling, General & Administrative Expenses for TXG have been equal to 57.76% of Gross Profit Margin.
- The Research & Development expenses have been 51.45% of Revenue.
- The Interest Expense is -0.29% of Operating Income.
- The Net Earning history of TXG is -32.15% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
10x Genomics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Information Services |
| Sector: | Healthcare |
| Current Symbol: | TXG |
| CUSIP: | 88025U |
| Website: | 10xgenomics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.37 |
| Quick Ratio: | 4.4 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 129.72 |
TXG Technical Analysis vs Fundamental Analysis
Buy
59
10x Genomics (TXG)
is a Buy
Is 10x Genomics a Buy or a Sell?
-
10x Genomics stock is rated a Buy
The current 10x Genomics [TXG] share price is $42.16. The Score for TXG is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.